Aarkstore - Alpha- Antitrypsin Deficiency - Pipeline Review, H2 2014

1
Aarkstore - Alpha- Antitrypsin Deficiency -
Pipeline Review, H2 2014
www.aarkstore.com
2
Summary

• Alzheimer's Disease - Pipeline Review, H2 2014,
  provides an overview of the
• Alzheimer's Diseases therapeutic pipeline.
• This Market Research Report provides
  comprehensive information on the therapeutic
• development for Alzheimer's Disease, complete
  with comparative analysis at various stages,
• therapeutics assessment by drug target, mechanism
  of action (MoA), route of administration
• (RoA) and molecule type, along with latest
  updates, and featured news and press releases. It
• also reviews key players involved in the
  therapeutic development for Alzheimer's
  Diseaseand
• special features on late-stage and discontinued
  projects.

www.aarkstore.com
3
Scope

• - The report provides a snapshot of the
  global therapeutic landscape of Alzheimer's
  Disease- The report reviews key pipeline
  products under drug profile section which
  includes, product description, MoA and RD brief,
  licensing and collaboration details other
  developmental activities - The report reviews
  key players involved in the therapeutics
  development for Alzheimer's Disease and enlists
  all their major and minor projects- The report
  summarizes all the dormant and discontinued
  pipeline projects - A review of the Alzheimer's
  Disease products under development by companies
  and universities/research institutes based on
  information derived from company and
  industry-specific sources- Pipeline products
  coverage based on various stages of development
  ranging from pre-registration till discovery and
  undisclosed stages- A detailed assessment of
  monotherapy and combination therapy pipeline
  projects

www.aarkstore.com
4
Reasons to buy

• - Provides strategically significant
  competitor information, analysis, and insights to
  formulate effective RD development strategies-
  Identify emerging players with potentially strong
  product portfolio and create effective
  counter-strategies to gain competitive
  advantage- Develop strategic initiatives by
  understanding the focus areas of leading
  companies- Identify and understand important and
  diverse types of therapeutics under development
  for Alzheimer's Disease- Plan mergers and
  acquisitions effectively by identifying key
  players of the most promising pipeline- Devise
  corrective measures for pipeline projects by
  understanding Alzheimer's Disease pipeline depth
  and focus of Indication therapeutics- Develop
  and design in-licensing and out-licensing
  strategies by identifying prospective partners
  with the most attractive projects to enhance and
  expand business potential and Scope

www.aarkstore.com
5
Table of Contents

• IntroductionAlzheimer's Disease
  OverviewTherapeutics DevelopmentAlzheimer's
  Disease - Therapeutics under Development by
  CompaniesAlzheimer's Disease - Therapeutics
  under Investigation by Universities/InstitutesAlz
  heimer's Disease - Pipeline Products
  GlanceAlzheimer's Disease - Products under
  Development by CompaniesAlzheimer's Disease -
  Products under Investigation by
  Universities/InstitutesAlzheimer's Disease -
  Companies Involved in Therapeutics
  DevelopmentAlzheimer's Disease - Therapeutics
  AssessmentDrug Profiles

www.aarkstore.com
6
List Of Tables

• Number of Products under Development for
  Alzheimer's Disease, H2 2014Number of Products
  under Development for Alzheimer's Disease -
  Comparative Analysis, H2 2014Number of Products
  under Development by Companies, H2 2014Number of
  Products under Investigation by
  Universities/Institutes, H2 2014Comparative
  Analysis by Clinical Stage Development, H2
  2014Comparative Analysis by Early Stage
  Products, H2 2014Assessment by Monotherapy
  Products, H2 2014Assessment by Combination
  Products, H2 2014Number of Products by Top 10
  Targets, H2 2014Number of Products by Stage and
  Top 10 Targets, H2 2014

www.aarkstore.com
7
List Of Figures

• Number of Products under Development for
  Alpha- Antitrypsin Deficiency, H2 2014 9Number
  of Products under Development for Alpha-
  Antitrypsin Deficiency - Comparative Analysis, H2
  2014 10Number of Products under Development by
  Companies, H2 2014 11Comparative Analysis by
  Clinical Stage Development, H2 2014
  14Comparative Analysis by Early Stage Products,
  H2 2014 15Assessment by Monotherapy Products, H2
  2014 32Number of Products by Top 10 Targets, H2
  2014 33Number of Products by Stage and Top 10
  Targets, H2 2014 34Number of Products by Top 10
  Mechanism of Actions, H2 2014 35Number of
  Products by Stage and Top 10 Mechanism of
  Actions, H2 2014 36

www.aarkstore.com
8
Related Market Research reports

• Blirt S.A. - Product Pipeline Review 2014
• Auris Medical Holding AG - Product Pipeline
  Review 2014
• Integral Molecular, Inc. - Product Pipeline
  Review 2014
• DaVinci Biosciences, LLC - Product Pipeline
  Review 2014
• Actavis plc - Product Pipeline Review - 2014

www.aarkstore.com
9
Related Market Research reports

• TiGenix NV - Product Pipeline Review 2014
• Egenix, Inc. - Product Pipeline Review 2014
• SkyePharma PLC - Product Pipeline Review 2014
• MediWound Ltd. - Product Pipeline Review 2014
• BioTech Tools s.a. - Product Pipeline Review -
  2014

www.aarkstore.com
10
Aarkstore - Alzheimers Disease - Pipeline Review,
H2 2014
Format Price
PDF 2500
Site Licence 5000
Enterprise Wide Licence  7500
www.aarkstore.com
11
Contact Us

• Office
• Office No. - 809, 8th Floor,
• B-Wing, Mahaavir Icon, 
• Plot No.- 89 90, Sector-15,
• CBD-Belapur, Navi Mumbai 400614, 
• Maharashtra, India.
• 24/7 Online Support 91 9987295242
• General Inquiries 91 - 22 2756 4953
• You Can Visit http//www.aarkstore.com
• OR Mail us at contact_at_aarkstore.com
• Blog http//www.aarkstore.com/blog/
• Conference http//conference.aarkstore.com/
• News http//www.aarkstore.com/news

www.aarkstore.com